Olaf van Tellingen

23PUBLICATIONS
116CO-AUTHORS
Molecular targetsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Toxicology (incl. clinical toxicology)Characterisation of biological macromoleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 07, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

|Feb 16, 2026
Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma.

Mark C de Gooijer, Daria M Fedorushkova, Ping Zhang

|Dec 29, 2025
C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.

Julia Yemelyanenko, Jinhyuk Bhin, Eline van der Burg

|Dec 02, 2025
Aberrant neural activity in the peritumoral cortex underlies the progression of tumor-associated seizures.

Bibi L J Bouwen, Anne Bolleboom, Yuanhong Tang

|Sep 30, 2025
Reanalysis of in vivo drug synergy validation study rules out synergy in most cases.

Olaf van Tellingen, Renee X de Menezes

|May 02, 2025
Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse Tissues.

Aristeidis Lentzas, Anna Their, Jos H Beijnen

Pageof 4

Frequent Collaborators

11 joint publications

Mark Cornelis de Gooijer

3 joint publications

Johanna Olweus

3 joint publications

Julien Champagne

3 joint publications

Onno B Bleijerveld